Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Joly

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent diseaseM K Wilson, E Pujade-Lauraine, D Aoki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2019
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysisA R Ferreira, A Di Meglio, B Pistilli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years laterA Di Meglio, J Havas, M Pagliuca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeI Vaz-Luis, M Masiero, G Cavaletti, et al.
Gynecologic Oncology|March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group StudyC Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancerA-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2018
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-upF Honecker, J Aparicio, D Berney, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent diseaseM K Wilson, E Pujade-Lauraine, D Aoki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2019
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysisA R Ferreira, A Di Meglio, B Pistilli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years laterA Di Meglio, J Havas, M Pagliuca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeI Vaz-Luis, M Masiero, G Cavaletti, et al.
Gynecologic Oncology|March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group StudyC Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancerA-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2018
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-upF Honecker, J Aparicio, D Berney, et al.
Pageof 17